Supriya Lifescience secures WHO GMP certificate for Ambernath facility

Supriya Lifescience Ltd. has secured a World Health Organisation (WHO) Good Manufacturing Practice (GMP) certificate for its Ambernath facility. The company announced on October 1, 2025, that the WHO conducted an audit on September 2, 2025, specifically for Inhalation Dosages at the facility.

Following the successful audit, the WHO issued the GMP certificate, confirming that the Ambernath facility is GMP compliant. This accreditation enables Supriya Lifescience to undertake production and sales from this facility and qualifies it for the distribution of products in international markets.

The company does not anticipate any material impact on its current business operations or existing supplies from the Ambernath facility as a result of this development.